Ontario scientists discovered insulin; August Krogh was given the rights to produce insulin in Scandinavia, which Krogh used ...

The latest biotech industry updates, complete with product launches, partnerships, publications and personnel appointments ...

Global hedge funds last week dumped the so-called Magnificent Seven megacap stocks, bringing their exposure to the group to a two-year low just ahead of their earnings, according to a Morgan Stanley ...

(Reuters) -Danish drugmaker Novo Nordisk has bought global rights to China-based United Laboratories International's so-called "triple-G" weight-loss drug candidate in a deal worth up to $2 billion.

UBT251 targets GLP-1, GIP, and a third hormone, glucagon, hence the name "triple G". Rival Eli Lilly is developing ... firms continue "to look to Chinese biotech names as a source for cheap ...

Cancer Gene Therapy Market Breast and Lung Cancer dominate, driven by high incidence and genetic testing integration. US, NY, UNITED ST ...

I believe that a good speculative biotech to go over for the "Exclusive ... This is broken down into US$6.3 million of G&A expenses and US$13.5 million in R&D expenses. There are several risks ...

Despite 2024 top-line numbers some analysts found disappointing, L’Oréal doubled down on profits, achieving record gross and ...